Drug Topics

MARCH 26, 2025

Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.

363

363

PharmaVoice

MARCH 26, 2025

A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.

147

147

Drug Topics

MARCH 26, 2025

Jasmine Cutler, PharmD, CPh, assistant professor in the department of pharmacy practice at the Taneja College of Pharmacy, discusses role of education and accessibility in reproductive health.

315

315

Fierce Healthcare

MARCH 26, 2025

The Centers for Disease Control and Prevention is reportedly rescinding $11.4 billion in funds to states, cities and organizations receiving grants for COVID-19 efforts.

136

136

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 26, 2025

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, also addresses personalized care and the expanding responsibilities of pharmacists.

311

311

Pharmacy Times

MARCH 26, 2025

Older age and being insured with Medicare or Medicaid were associated with heightened annual joint bleeding rates, whereas treatment in the Northeast United States improved outcomes in both hemophilia A and hemophilia B.

Insurance 116

Insurance 116

Pharmacy Times

MARCH 26, 2025

Patients with chronic lymphocytic leukemia (CLL) show weakened T-cell memory responses to COVID-19 vaccination.

Vaccines 112

Vaccines 112

Fierce Healthcare

MARCH 26, 2025

To prepare for the expansion, Two Chairs has added new clinicians to its team, including some who are cross-licensed to treat in multiple states. To date, the company focused on building its presence in California, Florida and Washington, where it also has in-person clinics.

109

109

Pharmacy Times

MARCH 26, 2025

Using Janus kinase inhibitors, having experienced a previous thrombosis episode, and higher age were associated with a heightened risk of a new thromboembolic event.

110

110

pharmaphorum

MARCH 26, 2025

Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

MARCH 26, 2025

Private equity's track record in healthcare could best be described as "mixed," with high-profile failures like the implosion of Steward Health Care setting a poor example. | Private investment will be even more critical for healthcare organizations in a political environment where public funds are likely to shrink.

103

103

Pharmaceutical Technology

MARCH 26, 2025

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity data.

Vaccines 97

Vaccines FDA 97

Pharmacy Times

MARCH 26, 2025

Adding daratumumab improved minimal residual disease (MRD) negativity rates, leading to superior progression-free survival (PFS).

89

89

pharmaphorum

MARCH 26, 2025

The UK is providing 2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia

82

82

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MARCH 26, 2025

About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.

73

73

pharmaphorum

MARCH 26, 2025

The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review

FDA 59

FDA 59

Pharmacy Times

MARCH 26, 2025

Will traditional PBMs adapt, or will disruptors take over?

73

73

Pharmaceutical Commerce

MARCH 26, 2025

Jen Butler, chief commercial officer, Pleio, discusses how the companys GoodStart programs help patients navigate specialty pharmacies.

Specialty Pharmacies 59

Specialty Pharmacies 59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MARCH 26, 2025

Community health workers improve patient care and address health care access gaps.

Patient Care 65

Patient Care 65

Pharmaceutical Commerce

MARCH 26, 2025

The Beijing location represents the sixth worldwide.

59

59

Pharmacy Times

MARCH 26, 2025

The hepatitis B core-related antigen (HBcrAg) rapid diagnostic test was more timely and showed a stronger sensitivity and specificity compared with other testing methods.

65

65

Pharmaceutical Technology

MARCH 26, 2025

Multinational companies in Chinas vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

Vaccines 59

Vaccines 59

Pharmacy Times

MARCH 26, 2025

Patients achieved statistically significant benefits in progression-free survival and overall response rates.

FDA 65

FDA 65

Pharmaceutical Commerce

MARCH 26, 2025

The latest news for pharma industry insiders.

59

59

Pharmacy Times

MARCH 26, 2025

In previously sedentary young males and females, 14 days of moderate aerobic exercise increased red and white blood cell counts and hemoglobin concentrations without altering key cardiometabolic enzymes.

65

65

Fierce Healthcare

MARCH 26, 2025

Dual-eligible beneficiaries are among the most expensive and complex patients out there. | Pair Team supports community-based organizations via California's Medi-Cal Community Care Hubs model.

58

58

Pharmacy Times

MARCH 26, 2025

The findings provide a deeper understanding of the mechanisms underlying breast cancer progression and treatment resistance.

65

65

pharmaphorum

MARCH 26, 2025

The growing burden of misinformation: Patients left wondering where to turn for trusted insights and support Mike.

52

52

Pharmaceutical Technology

MARCH 26, 2025

EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.

52

52

PharmExec

MARCH 26, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

Pharmaceutical Technology

MARCH 26, 2025

Ensuring the highest standards in pharmaceutical logistics is crucial for patient safety and treatment efficacy.

52

52

PharmExec

MARCH 26, 2025

Results from multiple clinical trials showed that Tagrisso demonstrated survival benefits in EGFR-mutated non-small cell lung cancer, both as monotherapy and in combination therapies.

52

52

Pharmaceutical Technology

MARCH 26, 2025

While Cassava is stopping investigations into simufilam in Alzheimers disease, the therapy is now being evaluated in TSC-related epilepsy.

52

52